Sedana Medical AB (FRA:7D2A)
€ 1.066 0.054 (5.34%) Market Cap: 110.49 Mil Enterprise Value: 91.51 Mil PE Ratio: 0 PB Ratio: 1.15 GF Score: 65/100

Q3 2021 Sedana Medical AB (publ) Earnings Call Transcript

Nov 04, 2021 / 12:30PM GMT
Release Date Price: €8.12 (+1.12%)
Operator

Hello, and welcome to the Sedana Medical Q3 Report for 2021. (Operator Instructions) Today, I am pleased to present CEO, Johannes Doll; CFO, Susanne Andersson; CMO, Peter Sackey; and Commercial Director, Jens Lindberg. Please begin your meeting.

Johannes Doll;publ;CEO;President
Sedana Medical AB

()-&

Thank you. Good afternoon, everybody, and good morning if you're dialing in from the U.S. My name is Johannes Doll, I'm the company's CEO. And since this is my first report for Sedana Medical, I will start with a very brief introduction about myself. Before joining Sedana Medical on October 1, I was the Chief Commercial Officer at Orexo, a Swedish-based pharmaceuticals company, where among other things I was responsible for building up the commercial operations in the United States and plus also leading our corporate development efforts and led our internal development pipeline. Before joining Orexo, I worked 8 years at McKinsey, where I helped clients both in the medical devices industry as well as the pharma

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot